glenholme specialist healthcare (southern region) limited

Live EstablishedMidHigh

glenholme specialist healthcare (southern region) limited Company Information

Share GLENHOLME SPECIALIST HEALTHCARE (SOUTHERN REGION) LIMITED

Company Number

05757165

Directors

Kent Phippen

Don Serratt

View All

Shareholders

glenholme healthcare group limited

Group Structure

View All

Industry

Other residential care activities

 

Registered Address

79 high street, eton, windsor, berkshire, SL4 6AF

glenholme specialist healthcare (southern region) limited Estimated Valuation

£3.5m

Pomanda estimates the enterprise value of GLENHOLME SPECIALIST HEALTHCARE (SOUTHERN REGION) LIMITED at £3.5m based on a Turnover of £5.3m and 0.67x industry multiple (adjusted for size and gross margin).

glenholme specialist healthcare (southern region) limited Estimated Valuation

£8.7m

Pomanda estimates the enterprise value of GLENHOLME SPECIALIST HEALTHCARE (SOUTHERN REGION) LIMITED at £8.7m based on an EBITDA of £1.7m and a 5.12x industry multiple (adjusted for size and gross margin).

glenholme specialist healthcare (southern region) limited Estimated Valuation

£12.7m

Pomanda estimates the enterprise value of GLENHOLME SPECIALIST HEALTHCARE (SOUTHERN REGION) LIMITED at £12.7m based on Net Assets of £4.7m and 2.74x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Glenholme Specialist Healthcare (southern Region) Limited Overview

Glenholme Specialist Healthcare (southern Region) Limited is a live company located in windsor, SL4 6AF with a Companies House number of 05757165. It operates in the other residential care activities n.e.c. sector, SIC Code 87900. Founded in March 2006, it's largest shareholder is glenholme healthcare group limited with a 100% stake. Glenholme Specialist Healthcare (southern Region) Limited is a established, mid sized company, Pomanda has estimated its turnover at £5.3m with high growth in recent years.

View Sample
View Sample
View Sample

Upgrade for unlimited company reports & a free credit check

Glenholme Specialist Healthcare (southern Region) Limited Health Check

Pomanda's financial health check has awarded Glenholme Specialist Healthcare (Southern Region) Limited a 4 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 4 areas for improvement. Company Health Check FAQs

Health Check Image
Health Rating4out of 5
positive_score

5 Strong

positive_score

3 Regular

positive_score

4 Weak

size

Size

annual sales of £5.3m, make it larger than the average company (£2.4m)

£5.3m - Glenholme Specialist Healthcare (southern Region) Limited

£2.4m - Industry AVG

growth

Growth

3 year (CAGR) sales growth of 20%, show it is growing at a faster rate (5.6%)

20% - Glenholme Specialist Healthcare (southern Region) Limited

5.6% - Industry AVG

production

Production

with a gross margin of 31.6%, this company has a comparable cost of product (36.7%)

31.6% - Glenholme Specialist Healthcare (southern Region) Limited

36.7% - Industry AVG

profitability

Profitability

an operating margin of 30.6% make it more profitable than the average company (7%)

30.6% - Glenholme Specialist Healthcare (southern Region) Limited

7% - Industry AVG

employees

Employees

with 124 employees, this is above the industry average (57)

124 - Glenholme Specialist Healthcare (southern Region) Limited

57 - Industry AVG

paystructure

Pay Structure

on an average salary of £24.8k, the company has an equivalent pay structure (£27.4k)

£24.8k - Glenholme Specialist Healthcare (southern Region) Limited

£27.4k - Industry AVG

efficiency

Efficiency

resulting in sales per employee of £42.5k, this is equally as efficient (£45.8k)

£42.5k - Glenholme Specialist Healthcare (southern Region) Limited

£45.8k - Industry AVG

debtordays

Debtor Days

it gets paid by customers after 34 days, this is later than average (20 days)

34 days - Glenholme Specialist Healthcare (southern Region) Limited

20 days - Industry AVG

creditordays

Creditor Days

its suppliers are paid after 5 days, this is quicker than average (9 days)

5 days - Glenholme Specialist Healthcare (southern Region) Limited

9 days - Industry AVG

stockdays

Stock Days

it holds stock equivalent to 0 days, this is less than average (0 days)

0 days - Glenholme Specialist Healthcare (southern Region) Limited

0 days - Industry AVG

cashbalance

Cash Balance

has cash to cover current liabilities for 0 weeks, this is less cash available to meet short term requirements (72 weeks)

0 weeks - Glenholme Specialist Healthcare (southern Region) Limited

72 weeks - Industry AVG

debtlevel

Debt Level

it has a ratio of liabilities to total assets of 56.7%, this is a higher level of debt than the average (29.6%)

56.7% - Glenholme Specialist Healthcare (southern Region) Limited

29.6% - Industry AVG

GLENHOLME SPECIALIST HEALTHCARE (SOUTHERN REGION) LIMITED financials

EXPORTms excel logo

Glenholme Specialist Healthcare (Southern Region) Limited's latest turnover from March 2024 is £5.3 million and the company has net assets of £4.7 million. According to their latest financial statements, Glenholme Specialist Healthcare (Southern Region) Limited has 124 employees and maintains cash reserves of £6 thousand as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015May 2014May 2013May 2012May 2011May 2010
Turnover5,272,5234,241,7113,479,2193,049,1522,652,8642,154,4051,267,711738,926721,058672,400804,4532,299,8024,158,6613,613,9713,595,476
Other Income Or Grants000000000000000
Cost Of Sales3,606,5393,270,5672,555,2912,357,2111,884,6411,434,789986,585555,143560,525468,745422,3161,603,1082,794,9682,399,3952,362,531
Gross Profit1,665,984971,144923,928691,941768,223719,616281,126183,783160,533203,655382,137696,6931,363,6941,214,5771,232,946
Admin Expenses53,024-574,848632,572-238,087-67,470346,32190,60265,50221,69220,961156,303542,0741,225,8511,119,8641,853,078
Operating Profit1,612,9601,545,992291,356930,028835,693373,295190,524118,281138,841182,694225,834154,619137,84394,713-620,132
Interest Payable372,758186,871128,863134,421118,93564,65955,21552,92856,69154,53564,00050,88237,91619,9080
Interest Receivable0000000000192,2852114242
Pre-Tax Profit1,240,2021,359,121162,493795,607716,758308,636135,30965,35382,150129,149357,292103,75899,92874,847-620,090
Tax-318,376-329,812-99,294-169,842-144,795-64,828-32,757-23,349-19,400-26,5630-23,864-23,983-19,4600
Profit After Tax921,8261,029,30963,199625,765571,963243,808102,55242,00462,750102,586357,29279,89475,94555,387-620,090
Dividends Paid000000000000000
Retained Profit921,8261,029,30963,199625,765571,963243,808102,55242,00462,750102,586357,29279,89475,94555,387-620,090
Employee Costs3,069,7152,408,1911,751,9661,694,5601,233,564837,542629,400320,767400,941354,291364,270967,7581,807,2301,591,5891,605,991
Number Of Employees12412382825742312022211850928182
EBITDA*1,692,0071,622,295375,3201,025,312919,232440,554240,962142,314166,298185,508229,835161,240156,673117,403-606,569

* Earnings Before Interest, Tax, Depreciation and Amortisation

Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015May 2014May 2013May 2012May 2011May 2010
Tangible Assets3,214,2143,176,7703,210,0133,259,7643,275,9745,153,6473,454,9802,360,4241,199,0451,222,3551,180,3161,182,5771,182,3981,177,0461,188,338
Intangible Assets0000000004442,71212,88423,056
Investments & Other4,825,0004,826,7503,725,0004,028,0113,363,4840000000000
Debtors (Due After 1 year)000000000000000
Total Fixed Assets8,039,2148,003,5206,935,0137,287,7756,639,4585,153,6473,454,9802,360,4241,199,0451,222,3591,180,3201,182,5811,185,1101,189,9301,211,394
Stock & work in progress2,9852,2752,1272,5001,850975475479300300300300300300300
Trade Debtors492,639407,838169,844133,113148,34548,42374,53228,91743,89260,14386,19795,11259,96559,32948,868
Group Debtors2,209,625000000036,678000000
Misc Debtors5,85744,55943,07542,61353,726106,74029,9028,5624,8732,9095,2340000
Cash6,00089,047263,864433,048464,14263,45420,21158,60021,45621,5041,3698,3497919616,778
misc current assets000000000000000
total current assets2,717,106543,719478,910611,274668,063219,592125,12096,558107,19984,85693,100103,76160,34459,82565,946
total assets10,756,3208,547,2397,413,9237,899,0497,307,5215,373,2393,580,1002,456,9821,306,2441,307,2151,273,4201,286,3421,245,4541,249,7551,277,340
Bank overdraft299,658152,212215,050220,203184,89695,206100,43856,58450,03098,99241,5020000
Bank loan000000000000000
Trade Creditors 58,37389,06931,3760000008,342386506,047958,249986,3451,016,542
Group/Directors Accounts0556,235660,3251,059,6451,056,8281,964,6641,175,4891,180,0150000000
other short term finances000000000000000
hp & lease commitments11,85800000000000000
other current liabilities83,16657,93439,41743,35334,13820,3766,2505,35038,08350,111134,5250000
total current liabilities453,055855,450946,1681,323,2011,275,8622,080,2461,282,1771,241,94988,113157,445176,413506,047958,249986,3451,016,542
loans5,027,7813,364,7283,474,6383,661,7293,884,1321,819,5671,909,9051,009,1011,060,7011,054,042961,9601,011,504554,094612,5630
hp & lease commitments19,76300000000000000
Accruals and Deferred Income000000000000000
other liabilities0000000000184,169175,205219,419213,100878,438
provisions601,064592,843314,247322,136181,30979,1715,0287,5631,0652,11300000
total long term liabilities5,648,6083,957,5713,788,8853,983,8654,065,4411,898,7381,914,9331,016,6641,061,7661,056,1551,146,1291,186,709773,513825,663878,438
total liabilities6,101,6634,813,0214,735,0535,307,0665,341,3033,978,9843,197,1102,258,6131,149,8791,213,6001,322,5421,692,7561,731,7621,812,0081,894,980
net assets4,654,6573,734,2182,678,8702,591,9831,966,2181,394,255382,990198,369156,36593,615-49,122-406,414-486,308-562,253-617,640
total shareholders funds4,654,6573,734,2182,678,8702,591,9831,966,2181,394,255382,990198,369156,36593,615-49,122-406,414-486,308-562,253-617,640
Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015May 2014May 2013May 2012May 2011May 2010
Operating Activities
Operating Profit1,612,9601,545,992291,356930,028835,693373,295190,524118,281138,841182,694225,834154,619137,84394,713-620,132
Depreciation79,04776,30383,96495,28483,53967,25950,43824,03327,4572,8144,0013,9138,65812,51813,563
Amortisation000000000002,70810,17210,1720
Tax-318,376-329,812-99,294-169,842-144,795-64,828-32,757-23,349-19,400-26,5630-23,864-23,983-19,4600
Stock710148-373650875500-4179000000300
Debtors2,255,724239,47837,193-26,34546,90850,72966,955-47,96422,391-28,379-3,68135,14763610,46148,868
Creditors-30,69657,69331,37600000-8,3427,956-505,661-452,202-28,096-30,1971,016,542
Accruals and Deferred Income25,23218,517-3,9369,21513,76214,126900-32,733-12,028-84,414134,5250000
Deferred Taxes & Provisions8,221278,596-7,889140,827102,13874,143-2,5356,498-1,0482,11300000
Cash flow from operations-880,0461,407,663258,7571,031,207842,554412,766139,619140,515103,089112,979-137,620-349,973103,95857,285360,805
Investing Activities
capital expenditure-116,491-43,060-34,213-79,0741,794,134-1,765,926-1,144,994-1,185,412-4,143-44,853-1,740-4,092-14,010-1,226-1,224,957
Change in Investments-1,7501,101,750-303,011664,5273,363,4840000000000
cash flow from investments-114,741-1,144,810268,798-743,601-1,569,350-1,765,926-1,144,994-1,185,412-4,143-44,853-1,740-4,092-14,010-1,226-1,224,957
Financing Activities
Bank loans000000000000000
Group/Directors Accounts-556,235-104,090-399,3202,817-907,836789,175-4,5261,180,0150000000
Other Short Term Loans 000000000000000
Long term loans1,663,053-109,910-187,091-222,4032,064,565-90,338900,804-51,6006,65992,082-49,544457,410-58,469612,5630
Hire Purchase and Lease Commitments31,62100000000000000
other long term liabilities000000000-184,1698,964-44,2146,319-665,338878,438
share issue-1,38726,03923,68800767,45782,0690040,15100002,450
interest-372,758-186,871-128,863-134,421-118,935-64,659-55,215-52,928-56,691-54,535128,285-50,861-37,915-19,86642
cash flow from financing764,294-374,832-691,586-354,0071,037,7941,401,635923,1321,075,487-50,032-106,47187,705362,335-90,065-72,641880,930
cash and cash equivalents
cash-83,047-174,817-169,184-31,094400,68843,243-38,38937,144-4820,135-6,9808,270-117-16,58216,778
overdraft147,446-62,838-5,15335,30789,690-5,23243,8546,554-48,96257,49041,5020000
change in cash-230,493-111,979-164,031-66,401310,99848,475-82,24330,59048,914-37,355-48,4828,270-117-16,58216,778

glenholme specialist healthcare (southern region) limited Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for glenholme specialist healthcare (southern region) limited. Get real-time insights into glenholme specialist healthcare (southern region) limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Glenholme Specialist Healthcare (southern Region) Limited Competitor Analysis

competitor_analysis_table_img

Perform a competitor analysis for glenholme specialist healthcare (southern region) limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other mid companies, companies in SL4 area or any other competitors across 12 key performance metrics.

glenholme specialist healthcare (southern region) limited Ownership

GLENHOLME SPECIALIST HEALTHCARE (SOUTHERN REGION) LIMITED group structure

Glenholme Specialist Healthcare (Southern Region) Limited has no subsidiary companies.

Ultimate parent company

2 parents

GLENHOLME SPECIALIST HEALTHCARE (SOUTHERN REGION) LIMITED

05757165

GLENHOLME SPECIALIST HEALTHCARE (SOUTHERN REGION) LIMITED Shareholders

glenholme healthcare group limited 100%

glenholme specialist healthcare (southern region) limited directors

Glenholme Specialist Healthcare (Southern Region) Limited currently has 3 directors. The longest serving directors include Mr Kent Phippen (Nov 2014) and Mr Don Serratt (Nov 2014).

officercountryagestartendrole
Mr Kent PhippenUnited Kingdom68 years Nov 2014- Director
Mr Don Serratt62 years Nov 2014- Director
Mr Stuart McLaughlan60 years Jun 2016- Director

P&L

March 2024

turnover

5.3m

+24%

operating profit

1.6m

+4%

gross margin

31.6%

+38.01%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

March 2024

net assets

4.7m

+0.25%

total assets

10.8m

+0.26%

cash

6k

-0.93%

net assets

Total assets minus all liabilities

glenholme specialist healthcare (southern region) limited company details

company number

05757165

Type

Private limited with Share Capital

industry

87900 - Other residential care activities

incorporation date

March 2006

age

19

incorporated

UK

ultimate parent company

accounts

Audit Exemption Subsidiary

last accounts submitted

March 2024

previous names

glenholme healthcare (ngc) limited (March 2021)

new generation care limited (June 2017)

accountant

GLENHOLME GROUP

auditor

-

address

79 high street, eton, windsor, berkshire, SL4 6AF

Bank

ROYAL BANK OF SCOTLAND(IOM)LTD

Legal Advisor

-

glenholme specialist healthcare (southern region) limited Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We found 10 charges/mortgages relating to glenholme specialist healthcare (southern region) limited. Currently there are 5 open charges and 5 have been satisfied in the past.

glenholme specialist healthcare (southern region) limited Capital Raised & Share Issues BETA

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for GLENHOLME SPECIALIST HEALTHCARE (SOUTHERN REGION) LIMITED. This can take several minutes, an email will notify you when this has completed.

glenholme specialist healthcare (southern region) limited Companies House Filings - See Documents

datedescriptionview/download